Found: 111
Select item for more details and to access through your institution.
Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Gamma-glutamyltranspeptidase levels as an aid in the management of human cancer.
- Published in:
- 1983
- By:
- Publication type:
- journal article
In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004-05 Prospective European Surveillance Initiative.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 1, p. 116, doi. 10.1093/jac/dkn124
- By:
- Publication type:
- Article
Susceptibility of Staphylococcus aureus isolated from skin and wound infections in the United States 2005-07: laboratory-based surveillance study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 1, p. 109, doi. 10.1093/jac/dkn149
- By:
- Publication type:
- Article
In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent Gram-positive and Gram-negative isolates of European origin.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 61, n. 3, p. 595, doi. 10.1093/jac/dkm492
- By:
- Publication type:
- Article
Infrequent occurrence of single mutations in topoisomerase IV and DNA gyrase genes among US levofloxacin-susceptible clinical isolates of Streptococcus pneumoniae from nine institutions (1999–2003).
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2006, v. 57, n. 3, p. 437, doi. 10.1093/jac/dki487
- By:
- Publication type:
- Article
Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Activity of faropenem, a new furanem, against European respiratory pathogens collected during 2000-2001: a comparison with other beta-lactam agents.
- Published in:
- 2003
- By:
- Publication type:
- research
Prevalence of Acinetobacter spp. isolates with reduced susceptibility to imipenem, as determined by a USA-wide electronic surveillance network.
- Published in:
- 1999
- By:
- Publication type:
- commentary
Activity of Ertapenem against Enterobacteriaceae in seven global regions—SMART 2012-2016.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2018, v. 37, n. 8, p. 1481, doi. 10.1007/s10096-018-3274-y
- By:
- Publication type:
- Article
Ceftolozane/Tazobactam and Imipenem/Relebactam Cross-Susceptibility Among Clinical Isolates of Pseudomonas aeruginosa From Patients With Respiratory Tract Infections in ICU and Non-ICU Wards—SMART United States 2017–2019.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 7, p. 1, doi. 10.1093/ofid/ofab320
- By:
- Publication type:
- Article
718. Activity of Ceftolozane–Tazobactam and Ceftazidime–Avibactam Against Clinical P. aeruginosa Isolates Collected in United States and Canada—SMART 2018.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S323, doi. 10.1093/ofid/ofz360.786
- By:
- Publication type:
- Article
724. The In Vitro Activity of Gepotidacin and Comparator Agents Against Anaerobic Bacterial Isolates.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S325, doi. 10.1093/ofid/ofz360.792
- By:
- Publication type:
- Article
692. In Vitro Antibacterial Activity of Cefiderocol Against a Multi-national Collection of Carbapenem-Nonsusceptible Gram-Negative Bacteria From Respiratory Infections: SIDERO-WT-2014–2017.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S313, doi. 10.1093/ofid/ofz360.760
- By:
- Publication type:
- Article
706. In Vitro Activity of Ceftazidime–Avibactam and Comparator Agents Against MDR Enterobacteriaceae and Pseudomonas aeruginosa Collected in Latin America During the ATLAS Global Surveillance Program 2016–2017.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S318, doi. 10.1093/ofid/ofz360.774
- By:
- Publication type:
- Article
696. Cefiderocol Susceptibility Against Molecularly Characterized Carbapenemase-Producing Gram-Negative Bacteria in North America and Europe Between 2014 and 2017: SIDERO-WT-2014 to -2016 Studies.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S315, doi. 10.1093/ofid/ofz360.764
- By:
- Publication type:
- Article
693. In Vitro Activity of Ceftazidime–Avibactam and Comparator Agents Against Enterobacteriaceae and Pseudomonas aeruginosa Collected From Patients with Bloodstream Infections as Part of the ATLAS Global Surveillance Program, 2014–2017.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S314, doi. 10.1093/ofid/ofz360.761
- By:
- Publication type:
- Article
680. In vitro Activity of Ceftazidime–Avibactam and Comparator Agents Against Pseudomonas aeruginosa from ICU and Non-ICU Wards Collected in Latin America and Globally as Part of the ATLAS Surveillance Program 2016–2017.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S310, doi. 10.1093/ofid/ofz360.748
- By:
- Publication type:
- Article
679. In vitro Activity of Cefiderocol (CFDC), a Novel Siderophore Cephalosporin, Against Difficult-to-Treat-Resistant (DTR) Gram-Negative Bacterial Pathogens From the Multi-National Sentinel Surveillance Study, SIDERO-WT (2014–2017).
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S309, doi. 10.1093/ofid/ofz360.747
- By:
- Publication type:
- Article
597. Cross-resistance of Ceftolozane-Tazobactam and Imipenem-Relebactam Against Clinical P. aeruginosa Isolates: SMART United States 2016–2018.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S281, doi. 10.1093/ofid/ofz360.666
- By:
- Publication type:
- Article
In Vitro Activity of Imipenem/Relebactam Against Gram-Negative Bacilli from Pediatric Patients—Study for Monitoring Antimicrobial Resistance Trends (SMART) global surveillance program 2015–2017.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2021, v. 10, n. 3, p. 274, doi. 10.1093/jpids/piaa056
- By:
- Publication type:
- Article
Epidemiology and Antimicrobial Susceptibility of Gram-Negative Pathogens Causing Intra-abdominal Infections in Pediatric Patients in Europe--SMART 2011-2014.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2017, v. 6, n. 1, p. 72, doi. 10.1093/jpids/piv109
- By:
- Publication type:
- Article
Clinically Actionable Insights into Initial and Matched Recurrent Glioblastomas to Inform Novel Treatment Approaches.
- Published in:
- Journal of Oncology, 2019, p. 1, doi. 10.1155/2019/4878547
- By:
- Publication type:
- Article
Clostridium difficile Culture-Positive Toxin-Negative Diarrhea.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1986, v. 81, n. 10, p. 940
- By:
- Publication type:
- Article
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in Greece and Italy—SMART 2017–2021.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2024, v. 43, n. 7, p. 1343, doi. 10.1007/s10096-024-04756-4
- By:
- Publication type:
- Article
In vitro activity of aztreonam–avibactam against Enterobacterales isolates collected in Latin America, Africa/Middle East, Asia, and Eurasia for the ATLAS Global Surveillance Program in 2019–2021.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2023, v. 42, n. 9, p. 1135, doi. 10.1007/s10096-023-04645-2
- By:
- Publication type:
- Article
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical gram-negative isolates from Czech Republic, Hungary, and Poland—SMART 2017–2020.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2023, v. 42, n. 3, p. 365, doi. 10.1007/s10096-023-04549-1
- By:
- Publication type:
- Article
Factors Influencing Fluoroquinolone Resistance.
- Published in:
- 2003
- By:
- Publication type:
- Letter
Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001.
- Published in:
- 2004
- By:
- Publication type:
- journal article
In Vivo Development of Teicoplanin Resistance in a VanB Enterococcus faecium Isolate.
- Published in:
- Journal of Infectious Diseases, 1993, v. 167, n. 5, p. 1224, doi. 10.1093/infdis/167.5.1224
- By:
- Publication type:
- Article
In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in Latin America: SMART 2018‒2020.
- Published in:
- Brazilian Journal of Infectious Diseases, 2023, v. 27, n. 3, p. 1, doi. 10.1016/j.bjid.2023.102775
- By:
- Publication type:
- Article
Epidemiology and in vitro activity of ceftazidimeavibactam and comparator agents against multidrugresistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015‒2020.
- Published in:
- Brazilian Journal of Infectious Diseases, 2023, v. 27, n. 3, p. 1, doi. 10.1016/j.bjid.2023.102759
- By:
- Publication type:
- Article
In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017-2019.
- Published in:
- Brazilian Journal of Infectious Diseases, 2021, v. 25, n. 6, p. 1, doi. 10.1016/j.bjid.2021.101647
- By:
- Publication type:
- Article
Resistance among Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Latin American countries: SMART 2013-2015.
- Published in:
- Brazilian Journal of Infectious Diseases, 2017, v. 21, n. 3, p. 343, doi. 10.1016/j.bjid.2017.03.006
- By:
- Publication type:
- Article
Recent trends in resistance to cell envelope-active antibacterial agents among key bacterial pathogens.
- Published in:
- Annals of the New York Academy of Sciences, 2013, v. 1277, n. 1, p. 1, doi. 10.1111/nyas.12022
- By:
- Publication type:
- Article
Pharmacodynamic evaluation of i.v. antimicrobials against Pseudomonas aeruginosa samples collected from U.S. hospitals.
- Published in:
- American Journal of Health-System Pharmacy, 2011, v. 68, n. 17, p. 1619, doi. 10.2146/ajhp100569
- By:
- Publication type:
- Article
MR Imaging and Clinical Characteristics of Diffuse Glioneuronal Tumor with Oligodendroglioma-like Features and Nuclear Clusters.
- Published in:
- American Journal of Neuroradiology, 2022, v. 43, n. 10, p. 1523, doi. 10.3174/ajnr.A7647
- By:
- Publication type:
- Article
Activity of ceftolozane/tazobactam against Gram-negative isolates from patients with lower respiratory tract infections – SMART United States 2018–2019.
- Published in:
- BMC Microbiology, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12866-021-02135-z
- By:
- Publication type:
- Article
Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States.
- Published in:
- Annals of Clinical Microbiology & Antimicrobials, 2006, v. 5, p. 1, doi. 10.1186/1476-0711-5-2
- By:
- Publication type:
- Article
Emerging resistance among bacterial pathogens in the intensive care unit -- a European and North American Surveillance study (2000-2002).
- Published in:
- Annals of Clinical Microbiology & Antimicrobials, 2004, v. 3, p. 14, doi. 10.1186/1476-0711-3-14
- By:
- Publication type:
- Article
Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002.
- Published in:
- Annals of Clinical Microbiology & Antimicrobials, 2004, v. 3, p. 7, doi. 10.1186/1476-0711-3-7
- By:
- Publication type:
- Article
Prevalence of antimicrobial resistance in bacteria isolated from central nervous system specimens as reported by U.S. hospital laboratories from 2000 to 2002.
- Published in:
- Annals of Clinical Microbiology & Antimicrobials, 2004, v. 3, p. 3, doi. 10.1186/1476-0711-3-3
- By:
- Publication type:
- Article
Tracking the implementation of NCCLS M100-S12 expanded-spectrum cephalosporin MIC breakpoints for nonmeningeal isolates of Streptococcus pneumoniae by clinical laboratories in the United States during 2002 and 2003.
- Published in:
- Annals of Clinical Microbiology & Antimicrobials, 2004, v. 3, p. 1, doi. 10.1186/1476-0711-3-1
- By:
- Publication type:
- Article
Ein neuartiges Verfahren zur Lebensdauerüberwachung wechselbelasteter Bauteile.
- Published in:
- Materialwissenschaft und Werkstoffechnik, 1979, v. 10, n. 10, p. 353, doi. 10.1002/mawe.19790101007
- By:
- Publication type:
- Article
GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma.
- Published in:
- British Journal of Dermatology, 2020, v. 183, n. 5, p. 928, doi. 10.1111/bjd.18947
- By:
- Publication type:
- Article
Endothelial Indoleamine-2,3-Dioxygenase-1 is not Critically Involved in Regulating Antitumor Immunity in the Central Nervous System.
- Published in:
- International Journal of Tryptophan Research, 2023, p. 1, doi. 10.1177/11786469231153111
- By:
- Publication type:
- Article
Endothelial Indoleamine-2,3-Dioxygenase-1 is not Critically Involved in Regulating Antitumor Immunity in the Central Nervous System.
- Published in:
- International Journal of Tryptophan Research, 2023, v. 16, p. 1, doi. 10.1177/11786469231153111
- By:
- Publication type:
- Article
Trends in Antibiotic Resistance Among Ocular Microorganisms in the United States From 2009 to 2018.
- Published in:
- 2020
- By:
- Publication type:
- journal article